Patent · US Active

Quinoline compounds as IRAK inhibitors and uses thereof

US11542246B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 15, 2019
Grant dateJan 3, 2023
Priority date—
Expiry dateJan 15, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.